InMed Pharmaceuticals Inc (INM)

[rosie10]

InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$304,500
Vancouver, BC – July 28, 2016 - InMed Pharmaceuticals, Inc. (“InMed”) (CSE: IN; OTCQB:
IMLFF), further to its release of July 19, 2016 is pleased to announce the closing of a non-brokered
private placement (the “Financing”) for 4,350,000 units (“Units”), at a price of $0.07 per Unit for gross
proceeds of C$304,500.00. Each Unit will consist of one common share and one non-transferable
share purchase warrant (a “Warrant”). Each Warrant will be exercisable by the holder to acquire one
additional common share at a price of $0.15 for a period of twelve (12) months expiring on July 28,
2017. All of the Units issued in connection with the Financing and Common Shares issued on
exercise of the Warrants will be subject to a restricted resale period that expires on November 29,
2016.
Finders’ fees of 7% on a portion of the gross proceeds received by the Company from the sale of
Units sold pursuant to the Financing shall include cash of $1,960.00, and 28,000 warrants (“Agent
Warrants”). Each Agent Warrant shall be exercisable in whole or in part at an exercise price of
$0.15 for a period of 12 months expiring on July 28, 2017.
The proceeds from this private placement will be used for general working capital purposes and a
portion will be used to settle debt.

www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=21434